276 related articles for article (PubMed ID: 27747572)
1. Promoting Safer Use of High-Risk Pharmacotherapy: Impact of Pharmacist-Led Targeted Medication Reviews.
Morrison C; MacRae Y
Drugs Real World Outcomes; 2015 Sep; 2(3):261-271. PubMed ID: 27747572
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist-led medication therapy management of diabetes club patients at a primary healthcare clinic in Cape Town, South Africa: A retrospective and prospective audit.
Sonday F; Bheekie A; Van Huyssteen M
S Afr Med J; 2022 May; 112(6):437-445. PubMed ID: 36217874
[TBL] [Abstract][Full Text] [Related]
3. Pharmacist-led medication review to identify medication-related problems in older people referred to an Aged Care Assessment Team: a randomized comparative study.
Elliott RA; Martinac G; Campbell S; Thorn J; Woodward MC
Drugs Aging; 2012 Jul; 29(7):593-605. PubMed ID: 22715865
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical counseling: Between evidence-based medicine and profits.
Egorova SN; Akhmetova T
Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
[TBL] [Abstract][Full Text] [Related]
5. A collaborative pharmacist prescribing model for patients with chronic disease(s) attending Australian general practices: Patient and general practitioner perceptions.
Percival M; McMurray A; Freeman C; Cottrell N
Explor Res Clin Soc Pharm; 2023 Mar; 9():100236. PubMed ID: 36923064
[TBL] [Abstract][Full Text] [Related]
6. Structured medication reviews in Parkinson's disease: pharmacists' views, experiences and needs - a qualitative study.
Oonk NGM; Dorresteijn LDA; Te Braake E; Movig KLL; van der Palen J; Nijmeijer HW; van Kesteren ME; Bode C
Ther Adv Drug Saf; 2024; 15():20420986241237071. PubMed ID: 38694547
[TBL] [Abstract][Full Text] [Related]
7. [AN INVESTIGATION INTO THE ROLE OF A REHABILITATION HOSPITAL PHARMACIST IN DETERMINING DISCREPANCIES AND MEDICATION ERRORS DURING PATIENTS` ADMISSION].
Yariv H; Dvir D
Harefuah; 2018 Sep; 157(9):576-581. PubMed ID: 30221857
[TBL] [Abstract][Full Text] [Related]
8. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic.
Lobas NH; Lepinski PW; Abramowitz PW
Am J Hosp Pharm; 1992 Jul; 49(7):1681-8. PubMed ID: 1621723
[TBL] [Abstract][Full Text] [Related]
9. Drug-related problems in general practice: results from a development project in Denmark.
Soendergaard B; Kirkeby B; Dinsen C; Herborg H; Kjellberg J; Staehr P
Pharm World Sci; 2006 Apr; 28(2):61-4. PubMed ID: 16947067
[TBL] [Abstract][Full Text] [Related]
10. Medication errors in HIV-infected hospitalized patients: a pharmacist's impact.
Eginger KH; Yarborough LL; Inge LD; Basile SA; Floresca D; Aaronson PM
Ann Pharmacother; 2013; 47(7-8):953-60. PubMed ID: 23737513
[TBL] [Abstract][Full Text] [Related]
11. Impact of Pharmacist-Conducted Comprehensive Medication Reviews for Older Adult Patients to Reduce Medication Related Problems.
Kiel WJ; Phillips SW
Pharmacy (Basel); 2017 Dec; 6(1):. PubMed ID: 29301226
[TBL] [Abstract][Full Text] [Related]
12. Piloting the role of a pharmacist in a community palliative care multidisciplinary team: an Australian experience.
Hussainy SY; Box M; Scholes S
BMC Palliat Care; 2011 Oct; 10():16. PubMed ID: 22035160
[TBL] [Abstract][Full Text] [Related]
13. Pharmacist-led interventions improve quality of medicine-related healthcare service at hospital discharge.
Duedahl TH; Hansen WB; Kjeldsen LJ; Graabæk T
Eur J Hosp Pharm; 2018 Mar; 25(e1):e40-e45. PubMed ID: 31157065
[TBL] [Abstract][Full Text] [Related]
14. Falls prevention focused medication review by a pharmacist in an acute hospital: implications for future practice.
Browne C; Kingston C; Keane C
Int J Clin Pharm; 2014 Oct; 36(5):969-75. PubMed ID: 25108410
[TBL] [Abstract][Full Text] [Related]
15. Impact of pharmacist intervention on clinical outcomes in the palliative care setting.
Wilson S; Wahler R; Brown J; Doloresco F; Monte SV
Am J Hosp Palliat Care; 2011 Aug; 28(5):316-20. PubMed ID: 21115471
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of pharmacist-led medicines review services in New Zealand - is there equity for Māori older adults?
Hikaka J; Hughes C; Jones R; Connolly MJ; Martini N
Res Social Adm Pharm; 2019 Dec; 15(12):1383-1394. PubMed ID: 30733137
[TBL] [Abstract][Full Text] [Related]
18. The potential role for a pharmacist in a multidisciplinary general practitioner super clinic.
Bajorek B; LeMay K; Gunn K; Armour C
Australas Med J; 2015; 8(2):52-63. PubMed ID: 25810788
[TBL] [Abstract][Full Text] [Related]
19. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
[TBL] [Abstract][Full Text] [Related]
20. Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists.
O'Mahony C; Dalton K; O'Hagan L; Murphy KD; Kinahan C; Coyle E; Sahm LJ; Byrne S; Kirke C
Int J Clin Pharm; 2024 May; ():. PubMed ID: 38814513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
